Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fontan Procedure | 16 | 2022 | 19 | 6.140 |
Why?
|
| Heart Defects, Congenital | 13 | 2022 | 95 | 5.410 |
Why?
|
| Models, Cardiovascular | 13 | 2021 | 76 | 3.360 |
Why?
|
| Hemodynamics | 16 | 2022 | 233 | 2.740 |
Why?
|
| Patient-Specific Modeling | 8 | 2021 | 10 | 1.950 |
Why?
|
| Pulmonary Artery | 6 | 2022 | 90 | 0.880 |
Why?
|
| Computer Simulation | 5 | 2020 | 454 | 0.850 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2022 | 150 | 0.850 |
Why?
|
| Clinical Decision-Making | 3 | 2019 | 140 | 0.800 |
Why?
|
| Heart Valve Prosthesis | 3 | 2022 | 89 | 0.780 |
Why?
|
| Cardiovascular System | 1 | 2021 | 41 | 0.720 |
Why?
|
| Echocardiography, Doppler | 1 | 2021 | 131 | 0.710 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 2030 | 0.690 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 43 | 0.660 |
Why?
|
| Blood Viscosity | 1 | 2017 | 4 | 0.600 |
Why?
|
| Materials Testing | 1 | 2018 | 77 | 0.590 |
Why?
|
| Adolescent | 11 | 2022 | 5912 | 0.510 |
Why?
|
| Heart Ventricles | 3 | 2021 | 250 | 0.480 |
Why?
|
| Hydrodynamics | 4 | 2021 | 33 | 0.400 |
Why?
|
| Exercise | 4 | 2022 | 913 | 0.380 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2022 | 114 | 0.340 |
Why?
|
| Humans | 22 | 2022 | 59189 | 0.340 |
Why?
|
| Child | 7 | 2022 | 4295 | 0.330 |
Why?
|
| Blood Flow Velocity | 2 | 2018 | 69 | 0.300 |
Why?
|
| Respiration | 2 | 2018 | 87 | 0.290 |
Why?
|
| Young Adult | 8 | 2022 | 4314 | 0.270 |
Why?
|
| Male | 12 | 2020 | 27445 | 0.260 |
Why?
|
| Female | 13 | 2021 | 30767 | 0.250 |
Why?
|
| Liver | 2 | 2019 | 782 | 0.220 |
Why?
|
| Coronary Circulation | 2 | 2021 | 52 | 0.220 |
Why?
|
| Polytetrafluoroethylene | 1 | 2022 | 18 | 0.210 |
Why?
|
| Patient Selection | 3 | 2019 | 445 | 0.210 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 9 | 0.190 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 35 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1024 | 0.170 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 50 | 0.170 |
Why?
|
| Thrombosis | 2 | 2020 | 195 | 0.160 |
Why?
|
| Liver Circulation | 1 | 2018 | 11 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 19 | 0.160 |
Why?
|
| Forecasting | 1 | 2019 | 221 | 0.160 |
Why?
|
| Reoperation | 1 | 2019 | 249 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 108 | 0.160 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 94 | 0.150 |
Why?
|
| Child, Preschool | 3 | 2019 | 1834 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 158 | 0.150 |
Why?
|
| Stress, Mechanical | 1 | 2018 | 111 | 0.150 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 55 | 0.150 |
Why?
|
| Thinness | 1 | 2017 | 39 | 0.140 |
Why?
|
| Prosthesis Design | 1 | 2018 | 202 | 0.140 |
Why?
|
| Pulmonary Veins | 1 | 2017 | 35 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1056 | 0.140 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 69 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 174 | 0.140 |
Why?
|
| Benchmarking | 1 | 2018 | 135 | 0.140 |
Why?
|
| Lung | 1 | 2021 | 822 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2019 | 1127 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2018 | 1907 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 4996 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2019 | 5959 | 0.090 |
Why?
|
| Mitral Valve | 2 | 2022 | 103 | 0.090 |
Why?
|
| Quality of Life | 3 | 2022 | 1108 | 0.080 |
Why?
|
| Adult | 4 | 2022 | 15708 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 199 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2324 | 0.060 |
Why?
|
| Animals | 2 | 2019 | 19556 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2460 | 0.050 |
Why?
|
| Lacerations | 1 | 2021 | 16 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 5061 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2018 | 3093 | 0.050 |
Why?
|
| Time Factors | 2 | 2018 | 3561 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2022 | 240 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 58 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 110 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 26 | 0.040 |
Why?
|
| Philadelphia | 1 | 2018 | 16 | 0.040 |
Why?
|
| Georgia | 1 | 2018 | 88 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2020 | 164 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 373 | 0.040 |
Why?
|
| Ventricular Function | 1 | 2018 | 21 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 338 | 0.040 |
Why?
|
| Anthropometry | 1 | 2017 | 80 | 0.040 |
Why?
|
| Compliance | 1 | 2017 | 5 | 0.040 |
Why?
|
| Anaerobic Threshold | 1 | 2017 | 10 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5134 | 0.040 |
Why?
|
| Leg | 1 | 2017 | 82 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2017 | 89 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 100 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1544 | 0.030 |
Why?
|
| Exercise Test | 1 | 2017 | 233 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 13272 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 248 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1525 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 672 | 0.030 |
Why?
|
| Middle Aged | 1 | 2021 | 16210 | 0.010 |
Why?
|